D001851DisordersC05.116.198590.989875Bone Diseases, Metaboliccmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson27871226Job F, Mizumoto S, Smith L, Couser N, Brazil A, Saal H, Patterson M, Gibson MI, Soden S, Miller N, Thiffault I, Saunders C, Yamada S, Hoffmann K, Sugahara K, Farrow EBMC medical geneticsJob F, Mizumoto S, Smith L, Couser N, Brazil A, Saal H, Patterson M, Gibson MI, Soden S, Miller N, Thiffault I, Saunders C, Yamada S, Hoffmann K, Sugahara K, Farrow E. Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype. BMC Med Genet. 2016 Nov 21; 17(1):86.BMC Med Genet2016-11-21T00:00:002016Functional validation of novel compound heterozygous variants in B3GAT3 resulting in severe osteopenia and fractures: expanding the disease phenotype.29552709VanSickle JS, Srivastava T, Alon USPediatric nephrology (Berlin, Germany)VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.Pediatr Nephrol2018-03-19T00:00:002018Use of calcimimetics in children with normal kidney function.MDSarahSodenSarah E. Soden0.000000000000000.00000000000000111Soden, SarahDivision Director2Associate Professor1ProfessorPhD, CGCEmilyFarrowEmily G. Farrow0.000000000000000.00000000000000124Farrow, EmilyDirector of Lab OperationsPhDElinGrundbergElin Grundberg0.000000000000000.00000000000000138Grundberg, Elin0000-0001-5415-7896Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research PediatricsResearchClinicalMD, FASNTarakSrivastavaTarak Srivastava39.08346750000000-94.5771129000000043Srivastava, TarakPediatric NephrologyChildren's Mercy Kansas CityMD, FAAP, FACMG, CCDEricRushEric T. Rush0.000000000000000.00000000000000200Rush, Eric0000-0002-8147-7315Medical Director, Office of Faculty Affairs and Development22876544Rush ET, DeHaai K, Kreikemeier RM, Lutz REJournal of pediatric endocrinology & metabolism : JPEMRush ET, DeHaai K, Kreikemeier RM, Lutz RE. Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings. J Pediatr Endocrinol Metab. 2012; 25(5-6):493-7.J Pediatr Endocrinol Metab2012-01-01T00:00:002012Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings.22935217Sebestyen JF, Srivastava T, Alon USClinical pediatricsSebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr (Phila). 2012 Nov; 51(11):1011-24.Clin Pediatr (Phila)2012-08-30T00:00:002012Bisphosphonates use in children.28888853Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono KMolecular genetics and metabolismKishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 09; 122(1-2):4-17.Mol Genet Metab2017-07-25T00:00:002017Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.true1Division DirectorDivision Director0.595140.1487855research area of0.6589410.0602188subject area fortrue1Pediatric NephrologyPediatric Nephrologytrue1Director of Lab OperationsDirector of Lab Operationstrue1Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research true1Medical Director, Office of Faculty Affairs and DevelopmentMedical Director, Office of Faculty Affairs and Development